Lipella Pharmaceuticals Inc. SEC filings LIPO
Lipella Pharmaceuticals Inc. has 225 filings in SEC EDGAR's recent list, going back to Dec 9, 2005. Its latest annual report, Form 10-K, was filed on Mar 28, 2025 for the period ended Dec 31, 2024. The latest quarterly report (Form 10-Q) was filed on Nov 14, 2025, covering the quarter ended Sep 30, 2025. The most recent current report (Form 8-K) was filed on Jul 15, 2026 (bankruptcy). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| PRE 14A | Preliminary proxy statement | Jun 10, 2025 | Jul 21, 2025 |
| DEFA14A | Additional proxy material | Dec 20, 2024 | — |
| DEFA14A | Additional proxy material | Dec 6, 2024 | — |
| DEF 14A | Proxy statement | Nov 12, 2024 | Dec 6, 2024 |
| PRE 14A | Preliminary proxy statement | Nov 1, 2024 | Dec 6, 2024 |
| DEF 14A | Proxy statement | Aug 12, 2024 | Sep 10, 2024 |
| PRE 14A | Preliminary proxy statement | Jul 30, 2024 | Jul 30, 2024 |
| DEFA14A | Additional proxy material | Oct 11, 2023 | — |
| DEF 14A | Proxy statement | Oct 10, 2023 | Nov 21, 2023 |
Showing 9 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LIPO (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Pittsburgh, PA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1347242
- Former names
- LIPELLA PHARMACEUTICALS INC (until Sep 11, 2023)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.